← Back to Search

Behavioural Intervention

Virtual Reality Therapy for Cancer-Related Symptoms

N/A

Waitlist Available

Research Sponsored by University of Maryland, Baltimore

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

English speaker (written and spoken)

Be older than 18 years old

Must not have

Current Hospice or palliative care only recipients

Impaired or uncorrected hearing

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to end of intervention (4 weeks)

Summary

"This trial aims to test a new method of managing symptoms in cancer patients after treatment using a Virtual Reality program. The goal is to see how this program affects pain, fatigue, sleep, and anxiety in

Who is the study for?

This trial is for cancer patients dealing with chronic pain, fatigue, sleep issues, or anxiety after their treatments. Participants should be comfortable using a Virtual Reality (VR) program at home and have symptoms that persist following cancer therapy.

What is being tested?

The study tests a Multimodal Integrative Therapy (MIT) delivered through VR called Relievrx, designed to manage symptoms like pain and anxiety in post-treatment cancer patients. The effectiveness of this FDA-authorized home-use program will be evaluated.

What are the potential side effects?

Since the intervention involves non-invasive VR therapy, side effects may include discomfort from wearing the VR headset, dizziness or motion sickness during use. No significant medical side effects are expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can speak and write in English.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am currently receiving only hospice or palliative care.

Select...

I have hearing problems that haven't been corrected.

Select...

I don't have any conditions that would prevent wearing a VR mask.

Select...

I have not been hospitalized for a severe psychiatric condition in the last 3 years.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to end of intervention (4 weeks)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to end of intervention (4 weeks)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to end of intervention (4 weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Audio effect on perceived anxiety

Audio effect on perceived depression

Audio effect on perceived fatigue

+9 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Virtual reality armExperimental Treatment1 Intervention

In the virtual reality intervention, participants will complete the scheduled educational module five times in the week of the intervention. This VR is assisting users in using immersive reality to reduce pain, learning cognitive and behavior self-coping skills and retraining the pain pathways. There are several sessions, which will be delivered using an all-in-one head-mounted display. Each session varies in duration approximately from 3 to 15 minutes.

Group II: Audio Mp4 armPlacebo Group1 Intervention

In the audio intervention, participants will complete the scheduled module 5 times a week of the intervention. The content is similar to that of the VR, which will be delivered by the audio player. Each session varies in duration approximately from 3 to 15 minutes.

0 / 5Eligibility criteria met